Figure 4From: Population pharmacokinetics and pharmacodynamics of cysteamine in nephropathic cystinosis patientsPercentage of patients with cystine concentrations below 1 nmol half-cystine/mg of protein (dashed lines) or below 2 nmol half-cystine/mg of protein (lines) according to bodyweight for the usual recommendations and for our dosing scheme (mg/kg/day) administered either in QID regimen or TID regimen.Back to article page